Gtree receives Korean approval to begin phase 2b/3 study of GBT-201 in patients with dry eye syndrome
Date
2015-07-22
Gtree receives Korean approval to begin phase 2b/3 study of GBT-201 in patients with dry eye syndrome
(if you want to view the body of article, click on the bottom link)
http://www.pharmabiz.com/NewsDetails.aspx?aid=89554&sid=2